103 related articles for article (PubMed ID: 24402660)
1. [Clinical and histological findings in Fabry nephropathy].
Pieruzzi F; Salerno F; Di Giacomo A; Torti G; Ferrario F; Pagni F; Stella A
G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402660
[TBL] [Abstract][Full Text] [Related]
2. Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.
Mignani R; Feriozzi S; Schaefer RM; Breunig F; Oliveira JP; Ruggenenti P; Sunder-Plassmann G
Clin J Am Soc Nephrol; 2010 Feb; 5(2):379-85. PubMed ID: 20056752
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy and Fabry nephropathy.
Warnock DG; Daina E; Remuzzi G; West M
Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of Fabry disease nephropathy.
Schiffmann R; Waldek S; Benigni A; Auray-Blais C
Clin J Am Soc Nephrol; 2010 Feb; 5(2):360-4. PubMed ID: 19965549
[TBL] [Abstract][Full Text] [Related]
5. [Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases].
Fomin VV; Pulin AA; Mukhin NA
Ter Arkh; 2013; 85(6):4-9. PubMed ID: 23866592
[TBL] [Abstract][Full Text] [Related]
6. Introduction to Focus on Fabry nephropathy: biomarkers, progression, and disease severity.
Warnock DG; Remuzzi G; Brenner BM; Levin A; Wanner C
Clin J Am Soc Nephrol; 2010 Feb; 5(2):359. PubMed ID: 20019119
[No Abstract] [Full Text] [Related]
7. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B
G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803
[TBL] [Abstract][Full Text] [Related]
8. The kidney in Fabry's disease.
Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
[TBL] [Abstract][Full Text] [Related]
9. Cardiac challenges in patients with Fabry disease.
Weidemann F; Linhart A; Monserrat L; Strotmann J
Int J Cardiol; 2010 May; 141(1):3-10. PubMed ID: 19720409
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C as a marker of early changes of renal function in Fabry nephropathy.
Feriozzi S; Germain DP; Di Vito R; Legrand A; Ricci R; Barbey F
J Nephrol; 2007; 20(4):437-43. PubMed ID: 17879210
[TBL] [Abstract][Full Text] [Related]
11. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.
Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Arning K; Baron R; Niemann M; Breunig F; Schaefer R; Strotmann J; Wanner C
Am J Med; 2010 Jul; 123(7):658.e1-658.e10. PubMed ID: 20609689
[TBL] [Abstract][Full Text] [Related]
12. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.
Terryn W; Cochat P; Froissart R; Ortiz A; Pirson Y; Poppe B; Serra A; Van Biesen W; Vanholder R; Wanner C
Nephrol Dial Transplant; 2013 Mar; 28(3):505-17. PubMed ID: 23234755
[TBL] [Abstract][Full Text] [Related]
13. Fabry disease: molecular genetics of the inherited nephropathy.
Desnick RJ; Astrin KH; Bishop DF
Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
[TBL] [Abstract][Full Text] [Related]
14. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
Desnick RJ; Banikazemi M
Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
[TBL] [Abstract][Full Text] [Related]
15. [Management of Fabry disease].
Constantin T; Székely A; Ponyi A; Gulácsy V; Ambrus C; Kádár K; Vastagh I; Dajnoki A; Tóth B; Bokrétás G; Müller V; Katona M; Medvecz M; Fiedler O; Széchey R; Varga E; Rudas G; Kertész A; Molnár S; Kárpáti S; Nagy V; Magyar P; Mahdi M; Rákóczi E; Németh K; Bereczki D; Garami M; Erdos M; Maródi L; Fekete G
Orv Hetil; 2010 Aug; 151(31):1243-51. PubMed ID: 20656661
[TBL] [Abstract][Full Text] [Related]
16. [Functional renal investigation in Fabry disease].
Froissart M; Benistan K; Germain DP
Presse Med; 2007 Mar; 36 Spec No 1():1S36-42. PubMed ID: 17546766
[TBL] [Abstract][Full Text] [Related]
17. [Rare renal diseases: diagnosis and nephrological mangement of Anderson-Fabry disease].
Ranieri E
G Ital Nefrol; 2009; 26(1):10. PubMed ID: 19255957
[No Abstract] [Full Text] [Related]
18. Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement.
Lobo T; Morgan J; Bjorksten A; Nicholls K; Grigg L; Centra E; Becker G
Intern Med J; 2008 Jun; 38(6):407-14. PubMed ID: 18613897
[TBL] [Abstract][Full Text] [Related]
19. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Breunig F; Wanner C
J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
[TBL] [Abstract][Full Text] [Related]
20. [Fabry disease--diagnostic guideline].
Constantin T; Rákóczi E; Ponyi A; Ambrus C; Kádár K; Vastagh I; Dajnoki A; Tóth B; Bokrétás G; Müller V; Katona M; Csikós M; Fiedler O; Széchey R; Varga E; Rudas G; Kertész A; Molnár S; Kárpáti S; Nagy V; Magyar P; Mahdi M; Németh K; Bereczki D; Garami M; Erdos M; Maródi L; Fekete G;
Orv Hetil; 2010 Feb; 151(7):243-9. PubMed ID: 20133243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]